Arrested development: suppression of NK cell function in the tumor microenvironment

被引:50
作者
Riggan, Luke [1 ,2 ]
Shah, Siya [1 ]
O'Sullivan, Timothy E. [1 ,2 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA
关键词
adoptive NK cell therapy; CRISPR; dysfunction; genetic engineering; immunotherapy; natural killer cells; suppression; tumor microenvironment;
D O I
10.1002/cti2.1238
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer (NK) cells are cytotoxic innate lymphocytes that protect against viral infection and tumor metastasis. Despite their inherent ability to kill a broad range of virally infected, stressed and transformed cells, low numbers of dysfunctional NK cells are often observed in many advanced solid human cancers. Here, we review the potential mechanisms that influence suboptimal mature NK cell recruitment and function in the tumor microenvironment (TME) of solid tumors. We further highlight current immunotherapy approaches aimed to circumvent NK cell dysfunction and discuss next-generation strategies to enhance adoptive NK cell therapy through targeting intrinsic and extrinsic checkpoints the regulate NK cell functionality in the TME. Understanding the mechanisms that drive NK cell dysfunction in the TME will lead to novel immunotherapeutic approaches in the fight against cancer.
引用
收藏
页数:17
相关论文
共 133 条
[41]   CD16-IL15-CD33 Trispecific Killer Engager (TriKE) Overcomes Cancer-Induced Immune Suppression and Induces Natural Killer Cell-Mediated Control of MDS and AML Via Enhanced Killing Kinetics [J].
Felices, Martin ;
Sarhan, Dhifaf ;
Brandt, Ludwig ;
Guldevall, Karolin ;
McElmurry, Ron ;
Lenvik, Alexander ;
Chu, Sami ;
Tolar, Jakub ;
Taras, Elizabeth ;
Spellman, Stephen R. ;
Warlick, Erica D. ;
Verneris, Michael R. ;
Cooley, Sarah ;
Weisdorf, Daniel ;
Blazar, Bruce R. ;
Onfelt, Bjorn ;
Vallera, Dan ;
Miller, Jeffrey S. .
BLOOD, 2016, 128 (22)
[42]   The Broad Spectrum of Human Natural Killer Cell Diversity [J].
Freud, Aharon G. ;
Mundy-Bosse, Bethany L. ;
Yu, Jianhua ;
Caligiuri, Michael A. .
IMMUNITY, 2017, 47 (05) :820-833
[43]   Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy [J].
Fujisaki, Hiroyuki ;
Kakuda, Harumi ;
Shimasaki, Noriko ;
Imai, Chihaya ;
Ma, Jing ;
Lockey, Timothy ;
Eldridge, Paul ;
Leung, Wing H. ;
Campana, Dario .
CANCER RESEARCH, 2009, 69 (09) :4010-4017
[44]   Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors [J].
Hargadon, Kristian M. ;
Johnson, Coleman E. ;
Williams, Corey J. .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 62 :29-39
[45]   Lactate-Mediated Acidification of Tumor Microenvironment Induces Apoptosis of Liver-Resident NK Cells in Colorectal Liver Metastasis [J].
Harmon, Cathal ;
Robinson, Mark W. ;
Hand, Fiona ;
Almuaili, Dalal ;
Mentor, Keno ;
Houlihan, Diarmaid D. ;
Hoti, Emir ;
Lynch, Lydia ;
Geoghegan, Justin ;
O'Farrelly, Cliona .
CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02) :335-346
[46]   The Immunological Genome Project: networks of gene expression in immune cells [J].
Heng, Tracy S. P. ;
Painter, Michio W. .
NATURE IMMUNOLOGY, 2008, 9 (10) :1091-1094
[47]   Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4 [J].
Holt, Dawn ;
Ma, Xinrong ;
Kundu, Namita ;
Fulton, Amy .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (11) :1577-1586
[48]   Enhanced NK-92 Cytotoxicity by CRISPR Genome Engineering Using Cas9 Ribonucleoproteins [J].
Huang, Rih-Sheng ;
Shih, Hsin-An ;
Lai, Min-Chi ;
Chang, Yao-Jen ;
Lin, Steven .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[49]   The cancer-natural killer cell immunity cycle [J].
Huntington, Nicholas D. ;
Cursons, Joseph ;
Rautela, Jai .
NATURE REVIEWS CANCER, 2020, 20 (08) :437-454
[50]   IL-15 trans-presentation promotes human NK cell development and differentiation in vivo [J].
Huntington, Nicholas D. ;
Legrand, Nicolas ;
Alves, Nuno L. ;
Jaron, Barbara ;
Weijer, Kees ;
Plet, Ariane ;
Corcuff, Erwan ;
Mortier, Erwan ;
Jacques, Yannick ;
Spits, Hergen ;
Di Santo, James P. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (01) :25-34